Verve Solution Revenue and Competitors

Navi Mumbai, IND

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Verve Solution's estimated annual revenue is currently $1.4M per year.(i)
  • Verve Solution's estimated revenue per employee is $40,800

Employee Data

  • Verve Solution has 35 Employees.(i)
  • Verve Solution grew their employee count by 0% last year.

Verve Solution's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$34.9M54818%N/AN/A
#2
$13.6M243-10%N/AN/A
#3
$29.6M46518%N/AN/A
#4
$9.3M1668%N/AN/A
#5
$6.7M1324%N/AN/A
#6
$11.4M20328%N/AN/A
#7
$2.7M597%N/AN/A
#8
$13.3M237-11%N/AN/A
#9
$2.7M592%N/AN/A
#10
$25M39236%N/AN/A
Add Company

What Is Verve Solution?

Established in 2015, Verve Solution is a full service B2B sales & marketing analytical company that offers end to end customized solutions to sales & marketing professionals. Verve Solution has it's headquarter in Mumbai-India. We serve to businesses of all sizes with all their sales & marketing information need, our customers are spread on the global geographies from Asia to EMEA and the Americas. We offer one stop solutions to customers from major industry verticals to few of the niche segments. Our clients are the major event and conference organizers, Commercial Publishers, Business Information Companies and IT solutions companies. With our proactive & consultative approach, we understand and deliver high end client experiment and support them increase their marketing ROI. For more information, please visit www.vervesol.com

keywords:N/A

N/A

Total Funding

35

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Verve Solution News

2022-04-20 - Lexus TX three-row SUV coming in about 18 months

... a “seemingly quick-and-dirty solution” to address the chasm in the Lexus lineup: Lack of a large, three-row SUV on a unibody chassis to...

2022-04-13 - Verve Therapeutics: Early-Stage Biotech With A Large Market

Summary. Verve Therapeutics is a biotechnology company with a vision to provide cutting-edge solutions to cardiovascular diseases. The company...

2022-03-30 - Verve Therapeutics Reports Durable and Well-Tolerated Editing of ANGPTL3 Gene Out to More than 20 Months in Non-Human Primates for Potential Treatment of Atherosclerotic Cardiovascular Disease

... a gene editing treatment solution for multiple patient populations. ... Verve expects to advance an in vivo ANGPTL3 base editing program...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.1M35N/AN/A
#2
N/A35-19%N/A
#3
$35M366%N/A
#4
$4.4M373%N/A
#5
$4.1M37N/AN/A